Two-dose therapy for S. aureus bloodstream infections on par with standard treatment
Wednesday, August 13, 2025 NIH-supported trial finds dalbavancin safe, effective for treating bacteremia Colorized scanning electron micrograph of…
Early clinical trial supports MASL as a targeted oral cancer treatment
Rowan University and Sentrimed®, a clinical-stage biopharmaceutical company focused on developing safer, orally dosed oncology therapies, today announced…